Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Prostate Cancer”

291 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 291 results

Early research (Phase 1)Study completedNCT02064036
What this trial is testing

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University of California, Davis 17
Not applicableWithdrawnNCT00963300
What this trial is testing

MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center
Not applicableNot Yet RecruitingNCT06945172
What this trial is testing

Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU

Who this might be right for
Prostate Cancer
GCS Ramsay Santé pour l'Enseignement et la Recherche 102
Not applicableLooking for participantsNCT06027892
What this trial is testing

Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer

Who this might be right for
PROSTATE CANCER
Rabin Medical Center 562
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)Ended earlyNCT00924807
What this trial is testing

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Medical Center 4
Not applicableStudy completedNCT02618161
What this trial is testing

Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment

Who this might be right for
Prostate Cancer
Mid and South Essex NHS Foundation Trust 100
Post-approval studies (Phase 4)Active Not RecruitingNCT06627530
What this trial is testing

COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer

Who this might be right for
Prostate Cancer
Brazilian Clinical Research Institute 144
Not applicableWithdrawnNCT00621413
What this trial is testing

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
IsoRay Medical, Inc.
Early research (Phase 1)Study completedNCT00026377
What this trial is testing

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 3
Not applicableUnknownNCT01972867
What this trial is testing

Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients

Who this might be right for
Prostate Cancer
Angiodynamics, Inc. 6
Not applicableStudy completedNCT00084552
What this trial is testing

Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer

Who this might be right for
Prostate CancerSexual DysfunctionSexuality and Reproductive Issues
Fox Chase Cancer Center 116
Early research (Phase 1)Study completedNCT02390063
What this trial is testing

Vaccination in Prostate Cancer (VANCE)

Who this might be right for
Prostate Cancer
University of Oxford 40
Not applicableLooking for participantsNCT07219303
What this trial is testing

Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Fox Chase Cancer Center 80
Not applicableStudy completedNCT01780701
What this trial is testing

Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03315754
What this trial is testing

Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.

Who this might be right for
Localized Prostate Cancer
Steba Biotech S.A. 50
Not applicableLooking for participantsNCT02865330
What this trial is testing

Spanish Urological Association Registry of Patients on Active Surveillance

Who this might be right for
Prostate Cancer
Fundación Instituto Valenciano de Oncología 946
Testing effectiveness (Phase 2)Study completedNCT01496131
What this trial is testing

Tecemotide (L-BLP25) in Prostate Cancer

Who this might be right for
Prostate Cancer
EMD Serono 28
Not applicableStudy completedNCT07489729
What this trial is testing

Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

Who this might be right for
Hypofractionated DoseProstate Cancer Patients
Tanta University 60
Testing effectiveness (Phase 2)UnknownNCT02643511
What this trial is testing

Hemiablative Focal Brachytherapy Pilot Study

Who this might be right for
Prostate Cancer
St George Hospital, Australia 20
Load More Results